Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check3 days agoChange DetectedThe government funding and NIH operating status notice has been removed from the page. This is a minor housekeeping change that does not affect the study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPosted results were added to the study page, including Results First Submitted: 2022-08-25 and Results First Posted: 2023-01-10. The Study Record Dates section and related results sections were updated accordingly.SummaryDifference0.3%

- Check46 days agoChange DetectedCore content updated with government funding status notice and operating status links, and version bumped from v3.1.0 to v3.2.0.SummaryDifference2%

- Check53 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision updates from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.